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Abstract: Recombinant expression of native or modified eukaryotic proteins is pivotal for structural
and functional studies and for industrial and pharmaceutical production of proteins. However, it is
often impeded by the lack of proper folding. Here, we present a stringent and broadly applicable
eukaryotic in vivo selection system for folded proteins. It is based on genetic complementation of
the Schizosaccharomyces pombe growth marker gene invertase fused C-terminally to a protein
library. The fusion proteins are directed to the secretion system, utilizing the ability of the
eukaryotic protein quality-control systems to retain misfolded proteins in the ER and redirect them
for cytosolic degradation, thereby only allowing folded proteins to reach the cell surface.
Accordingly, the folding potential of the tested protein determines the ability of autotrophic colony
growth. This system was successfully demonstrated using a complex insertion mutant library of
TNF-a, from which different folding competent mutant proteins were uncovered.
Keywords: protein folding; selection; protein engineering; folding quality control; heterologous
expression; eukaryote; in vivo selection; library construction; solubility; TNF-a; recombinant protein;
Schizosaccharomyces pombe; yeast; fission yeast; protein vaccine
Introduction
The recombinant expression of properly folded proteins is essential for the biotechnological and pharmaceuti-
cal applications of proteins. However, because of incorrect folding, numerous native and modified proteins are
not efficiently expressed in a soluble form and typically end up aggregating into inclusion bodies.
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To bypass this difficulty, different in vivo assays
for detection of soluble recombinant proteins have
been developed in E. coli. In these assays, the pro-
tein of interest is fused C-terminally to a reporter
protein. Foldable protein can then be selected based
on the comprehension that a misfolded insoluble pro-
tein, in most cases, causes elimination of the activity
of a C-terminally fused reporter protein. Several
reporter genes, for example, chloramphenicol acetyl-
transferase,1 green florescent protein (GFP),2,3 and
b-galactosidase,4 have been used in this type of
assay. Recently, a novel genetic selection assay for
protein folding was described in E. coli,5 based on
the observation that the transport through the bac-
terial twin-arginine translocation (Tat) pathway
depends on correct folding of the protein prior to
transport. Proteins of interest were fused C-termi-
nally to the reporter b-lactamase and directed
through the Tat pathway, through a signal peptide.
Hereafter, the survival of E. coli cells on the selec-
tive medium was correlated with the solubility of
the tested proteins. This assay represents a signifi-
cant improvement to the previously described meth-
ods as they simply discriminate between soluble and
insoluble proteins.
However, a major limitation of these systems is
that E. coli lacks the elaborate protein quality con-
trol machinery of eukaryotic cells and their ability
to perform important posttranslational modifications
on proteins. Most proteins of interest in biotechnol-
ogy are indeed of eukaryotic origin and are therefore
best expressed in a eukaryotic host. Consequently,
two screening systems have been developed in Sac-
charomyces cerevisiae.6,7 These assays are based on
the comprehension that proteins are directed to the
secretory pathway will be exported to the cell wall,
only if they fold. In contrast, misfolded protein var-
iants will be exported to the cytoplasm for proteaso-
mal degradation.8,9 In one assay, the tested protein
is fused to a small tag for antibody detection fol-
lowed by fluorescence activated cell sorting.6 In
another assay, a protein library is likewise combined
with an epitope tag, and screening is performed on
plates.7 One drawback of these assays is that they
require extensive screening and additional assaying
to get rid of false-positives. To eliminate these
obstacles, we have developed a versatile genetic
screening and selection system, based on the ER
protein quality control in the fission yeast Schizosac-
charomyces pombe.
Therapeutic recombinant human proteins will
play an increasingly important role in combating
human disease. Such proteins need to fold correctly
to retain functionality. For example, vaccination
against TNF-a, which is involved in chronic inflam-
mation, could represent an attractive anti-TNF-a
treatment10 for example, by the use of AutoVacTM
technology. This technology depends on inserting a
ubiquitous T-helper cell epitope into a native protein
of interest. The presence of the T-helper cell epitope
in the protein will increase its immunogenicity for
example, to circumvent tolerance to harmful self-
proteins. It is crucial that the epitope insertion does
not disrupt the folding and three-dimensional struc-
ture of the protein to preserve native B-cell epitopes
in the protein vaccine.
As proof of concept, we have applied our folding
selection assay to identify foldable species within a
library of human TNF-a insertion mutants, where
an oligonucleotide encoding the 13 amino acid long
T-helper cell epitope PADRE11 was inserted ran-
domly into the TNF-a sequence using a transposon-
based method. Using our selection system, we have
successfully identified 20 folded variants in this
library.
Results
Design of a eukaryotic protein-folding screening
and selection system
The selection system presented here is designed to
screen protein libraries to identify foldable species.
The selection system relies on the ability of the se-
cretory pathway of S. pombe to eliminate unfolded
proteins through the ER quality control system.8,9 S.
pombe has a well-organized and morphologically dis-
tinct golgi apparatus that performs many posttrans-
lational modifications similar to those in higher eu-
karyotic cells.12 Importantly, it is an easily cultured
single-cell eukaryote with a well developed genetic
toolbox including the ability to introduce vector
based gene libraries by transformation.
The S. pombe invertase gene was chosen as
selectable reporter, for five main reasons. First, the
invertase catalyses the hydrolysis of sucrose into
glucose and fructose13 that, unlike sucrose, can be
taken up by the cell and used for growth. This nutri-
tional marker permits efficient selection on medium
with sucrose, a sole carbon source, as only cells
expressing functional invertase will survive. Second,
invertase is a secretory protein14,15 and is therefore
not expected to influence transport negatively
through the secretory pathway. Third, the invertase
activity produced from a surviving clone can be
quantitated,16 and potentially, it provides a measure
for folding efficiency.17 Fourth, invertase has already
proven to be useful in screens, and fifth, it had pro-
ven tolerant to many different amino terminal
extensions,9,18,19 hence, allowing fusion to numerous
targets.
In our system, the cDNA encoding the proteins
subjected to selection is fused in frame to the 50-end
of the invertase gene. This configuration was chosen
for two reasons. First, the folding of the protein vari-
ant, rather than that of the invertase, is likely to
determine the overall secretion efficiency of the
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chimeric protein, as it reduces the possibility that
the reporter protein may act as a primer for folding.
Second, it ensures that no reporter protein activity
is expressed when species in the library of protein
variants contain a stop codon. To direct the different
protein library variants to the ER, they are N-termi-
nally fused to the signal peptide from carboxypepti-
dase Y (Cpy) from S. pombe,20 an export signal pre-
viously reported to direct TNF-a and other
recombinant proteins to the secretory pathway of S.
pombe21 (Fig. 1, Supporting Information Fig. A,
panel B).
After transformation of an invertase deficient S.
pombe strain (PY-17) with a plasmid-based library,
folded proteins are subsequently selected in a simple
growth-based assay on media containing sucrose as
the main carbon source. Minute amounts of glucose
(0.01, 0.02, or 0.03%) were added to the selective
media to allow all newly transformed cells to survive
on the sucrose media until the invertase gene begins
to express from the plasmid. As glucose is readily
used up by the plated cells, transformants, which
are not expressing invertase, cannot propagate to
form visible colonies. In this way, transformants
expressing invertase can easily be selected from
those that do not. The appropriate glucose concen-
trations were determined empirically through a
series of tests on control strains [Fig. 2(B)].
The assay discriminates between foldable
and nonfoldable proteins
To establish, whether the method indeed discrimi-
nates between folded and misfolded proteins, six test
proteins were fused to invertase and transformed
into PY-17. This set of proteins contains the three
foldable species, GFP, human TNF-a, and human
RANK-L, and a variant of human IL-5 that cannot
fold and be secreted (IL5.14, generated in a previous
study22) and two randomly picked variants of TNF-a
(variants 59 and 60) from our library (see later).
Finally, PY-17 was also transformed with a con-
struct, where a stop codon was inserted between the
signal peptide and the invertase sequences.
We first verified that only invertase fusions
with foldable proteins supported cell growth on
selective medium (Fig. 2). PY-17 transformed with a
construct containing invertase, TNF-invertase,
RANKL-invertase, or GFP-invertase could grow on a
nonselective medium and on a selective medium,
whereas PY-17 transformed with an IL5.14-invertase
construct or a construct, where a stop codon was
inserted between the signal peptide and the invert-
ase sequences, could only grow on a nonselective
medium. Next, we investigated the presence of the
invertase fusion proteins and their subcellular local-
ization using invertase activity16 measurements
(Table I), immunocytochemistry, and Western blots
(Fig. 3). Only strains transformed with invertase or
invertase C-terminally fused with a foldable protein
exhibited invertase activity. Invertase fusions with
IL5.14 and TNF-a variants 59 and 60 did not show
any activity. Invertase activity was solely associated
with intact cells as no invertase activity could be
detected in the culture medium. This indicates that
the fusion proteins were correctly secreted but
remained associated with the cell of S. pombe
through the invertase moiety, because the invertase
resides in the cell wall.23 This is important to keep
cross-feeding of cells that do not express invertase
activity by cells that do to a minimum. Western blot
experiments of total cell extracts (including cell and
cell wall content) and of culture medium demon-
strated that the cellular localization of the hybrid
proteins was determined by the invertase moiety.
Hence, GFP and TNF-a that were not extended by
invertase were secreted into the medium when
directed through the secretory pathway with the use
the signal peptide of Cpy. In agreement with these
results, we demonstrated that the GFP and TNF-a
invertase fusions were localized to the cell surface
by fluorescence microscopy [Fig. 3(B)]. In contrast,
IL5.14, a protein species that does not fold effi-
ciently, is retained within the cell when expressed
alone or fused with invertase.
As expected, GFP-invertase, TNF-a-invertase,
and RANKL-invertase transformants supported
growth on selective medium and displayed significant
levels of invertase activity, whereas the IL5.14-invert-
ase transformant did not. This shows that the selec-
tion system is indeed able to differentiate between
foldable and nonfoldable proteins. The cells trans-
formed with invertase fusions with TNF-a variants
59 and 60 displayed no invertase activity and growth.
This indicates that the assay can distinguish between
folded and misfolded TNF-a variants in our library
and that TNF-a variants 59 and 60 contain insertions
at nonpermissive sites. In the following, variants 59
and 60 are used as negative controls for folding. Alto-
gether, the growth on selective medium correlated
with expression of the invertase fusion proteins at
the cell surface and the invertase activity.
Construction of a TNF-a epitope insertion
library
To test the efficiency of our selection assay, we used
a TNF-a epitope insertion library as a model. Previ-
ously, a DNA transposition-based linker insertion
strategy has been used to generate genes encoding
proteins with random pentapeptide insertion.24 We
have modified this strategy to insert a 45-mer oligo-
nucleotide encoding the T-helper cell epitope PADRE
(AKFVAAWTLKAAA)11 into the pentapeptide
sequence (Supporting Information Fig. B), to pro-
duce a library of TNF-a insertion mutants. Our
strategy results in 17 amino acid long inserts within
the TNF-a sequence.
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Figure 1. Summary of the library generation and selection strategy used to identify foldable proteins in S. pombe.
(A) Construction of the TNF-a insertion Library: (Step 1) The Entranceposon (Finnzymes) and transposase react with the
acceptor plasmid (modified E. coli vector pUC19, containing the target cDNA (Supporting Information Fig. A, panel A),
resulting in random integration of the transposon herein. TNF-a is represented in blue and the transposon in cyan-blue. The
resulting plasmid collection is transformed into E. coli and amplified on LB solid medium containing both ampicillin and
kanamycin, ensuring selection only of plasmids with integrated transposon. (Step 2) The transposon can be integrated both in
the vector backbone and in the TNF-a gene. To eliminate the plasmids with transposons integrated into the vector backbone,
the TNF-a þ entranceposons sequences are reintroduced into the original pUC19 vector by use of the restriction enzymes
Nco1 and Sac1. (Step 3) Transformants are again selected on LB solid medium containing ampicillin and kanamycin. This is
important to eliminate any wild type TNF-a from the pool of variants that later could show up as false positives in the screen.
(Step 4) Now, the entranceposon is ready to be replaced with the PADRE epitope. To do so, the entranceposon is removed
by use of the restriction enzyme Not1. The open plasmid is ligated together with a DNA fragment encoding the PADRE
epitope, having compatible ends. The resulting plasmid is amplified on LB solid medium containing ampicillin. The TNF-a
library is ready for introduction into the screening vector. (B) Library generation and selection assay: The target cDNA (Red) is
subjected to transposon (Cyan-blue) and transposase, and consequently the transposon is introduced randomly into the
cDNA. In this study, the target cDNA encodes TNF-a. The transposon is genetically engineered. Hence, it can be removed by
the restriction enzyme Not1. After digesting the library with Not1, the transposon is interchanged by an insert DNA fragment
of choice (purple) containing compatible sticky ends. In this study, this insert contains the PADRE sequence [for details of the
library construction, see Fig. 1(A) and materials and methods]. Next, the library of cDNA’s is fused to the selectable genetic
marker invertase (Blue) and the Cpy signal sequence (Green) to produce a target-reporter plasmid library. This library is
introduced in an invertase null strain of S. pombe (PY-17). After translation, the protein enters the secretory pathway. Here,
misfolded proteins are retained and eventually targeted for degradation by the proteasome, whereas folded proteins go to the
surface. Here, the invertase marker supports growth on selective sucrose media by hydrolysing sucrose to the fermentable
monosaccharides glucose and fructose. Accordingly, only colonies encoding folding competent protein variants will survive
on selective sucrose media.
The constructed library contained approximately
17,500 individual species. If integration into the 474
bp TNF-a gene is truly random, this exceeds the
number of different theoretically attainable integra-
tion sites by approximately 20 times. The random-
ness of sequence integration was determined for 44
arbitrarily picked colonies. Each clone contained a
single insertion and when the integration points of
all variants were compared they were distributed
along the TNF-a sequence and did not appear to
cluster. Also, no favorable sequence orientation was
observed [Fig. 4(A) upper panel and Table II].
Hence, this random distribution, combined with the
relative size of the library, suggests that the library
contains most of the possible protein variants.
Identification of foldable TNF-a variants
using the protein folding screening
and selection assay
The TNF-a library was transferred to the S. pombe
expression vector, transformed into PY-17 and grown
on plates on selective medium. For selection, trans-
formants were plated on sucrose medium supple-
mented with the three different limiting concentra-
tions of 0.01, 0.02, and 0.03% glucose, as described
above. A total of  36,000 transformants (12,000 on
each selection medium) were subjected to selection
(Table III).
The growth rate of the transformants was fol-
lowed by visual inspection. As soon as the colonies
reached a diameter of 1–2 mm (7, 8, or 9 days after
transformation), they were picked from the selection
plates and individually streaked onto fresh plates
containing pure sucrose medium. This was done to
reduce growth of satellite colonies that otherwise
appear because of the cross feeding by glucose and
fructose diffusing from the positive colonies (data
not shown). Eighteen colonies were picked from
plates containing 0.01% glucose and seven plates
with 0.02% glucose.
On sucrose medium containing 0.03% glucose,
1068 colonies had formed after 7 days of growth.
This was significantly more than the growth in the
other two glucose concentrations, indicating that
this glucose concentration is too high to provide the
proper selective pressure needed to select for pro-
teins that fold efficiently. Therefore, all colonies
obtained on sucrose medium containing 0.03% glu-
cose were replica-plated onto pure sucrose media.
Following replica-plating, 11 colonies showed robust
growth. These were picked after 9 to 10 days and
restreaked as above. Thus, in total, 36 colonies were
selected from the three different selective media.
Finally, these colonies were restreaked twice on solid
sucrose media to validate their phenotype. After this
selection step, 26 transformants remained, which
equals to 0.07% of all transformants screened. These
clones were named clone 1–26.
After selection, the possibility existed that the
growth of a colony was because of the isolation of a
suppressor mutation in the S. pombe genome or
resulted from the transformation by more than one
plasmid into a single cell. Therefore, plasmids were
rescued from all 26 colonies, retransformed into PY-
17, and the transformants evaluated for growth abil-
ity on sucrose (data not shown). All the selected
plasmids were able to complement invertase activity,
except for four (clone 1, 20, 22, and 26). These four
clones were discarded without further characteriza-
tion. Hence, the final number of the selected clones
with foldable TNF-a variants by the assay was 22.
Sequence analysis of the selected TNF-a
insertion mutants
The plasmids from the 22 positive colonies were
sequenced to identify the insertion point and the
insert sequence within the individual TNF-a var-
iants [Fig. 4(A), lower panel, and Supporting Infor-
mation Fig. C]. Of these 22 clones, 20 were unique
and two TNF-a variants were found twice (clones 7/
24 and 9/17 were pair wise identical). Fourteen
unique permissive insertion sites were identified,
four of which could accommodate at least two differ-
ent insert sequences.
To evaluate the effect of the screening procedure
on the distribution of the epitope integration sites in
TNF-a, the sequences of the 20 unique TNF-a var-
iants were compared to those of the 44 randomly
picked clones obtained from the library before selec-
tive screening [Fig. 4(A)]. Before selection, insertions
were distributed evenly along the TNF-a sequence,
regardless of the secondary structure of the protein.
After screening, insertion sites were mapped to the
regions of low structural complexity, as they clus-
tered within the N-terminal region, C-terminus, or
in loops. Only two inserts were found in a sequence
encoding a b-strand (strand A and F, respectively)
[Figs. 4(A,B)]. These results strongly indicate that
the active selection for foldable protein has been tak-
ing place during the screen.
Importantly, when the collection of foldable
TNF-a variants was inspected for the presence of
the PADRE epitope, this sequence was found in six
cases and at five different insertion sites (clone 4, 7/
24, 12, 18, and 25). These proteins are therefore
TNF-a vaccine candidates.
The selected TNF-a variants ability to fold is not
dependent on the invertase moiety
The fact that the target protein is physically fused
to invertase, our screen opens the possibility that in-
vertase influences the folding efficiency and kinetics
of the target protein moiety. We therefore expressed
the five TNF-a vaccine candidates identified from
our library in S. pombe without the invertase moiety
to verify their folding properties. Wild-type TNF-a
Lyngso/ et al. PROTEIN SCIENCE VOL 19:579—592 583
Figure 2.
was used as a positive control and the two clones 59
and 60, which did not support growth on selective
medium (see above), were used as negative controls.
Secretion of TNF-a was monitored using ELISA
[Fig. 5(A)]. Only wild-type TNF-a and variant 25
were expressed at detectable levels in S. pombe. The
absence of detectable levels of variants 4, 7, 12, and
18 in S. pombe indicates that the selection assay is
more sensitive than the TNF-a ELISA test. Also, it
is known that S. pombe secretes high levels of pro-
teases in the growth media making exported folded
proteins prone to partial degradation.21,25 Such deg-
radation might affect only the detection in the
ELISA assay and not the ability to promote growth
of S. pombe colonies on sucrose. Therefore, the var-
iants were tested for soluble expression in E. coli
and Drosophila S2 cells, two commonly used hosts
for protein recombinant expression, which we have
previously used to express wild-type TNF-a (Nielsen,
et al. and unpublished data). Wild-type and all five
selected TNF-a variants, but not variants 59 and 60,
were expressed as soluble proteins at detectable lev-
els in E. coli and S2 cells [Fig. 5(A)]. The presence of
TNF-a variant in S2 cell cultures was also analyzed
by immunoblotting [Fig. 5(B)] and confirmed with
the ELISA results. These expression data confirm
that our selection system can distinguish foldable
from nonfoldable proteins in a complex library of
insertion mutants and that the invertase moiety
does not drive or influence folding of the target pas-
senger protein. In other hand, the expression levels
of TNF-a variants were much lower in S. pombe
than in the other two expression systems, indicating
that our S. pombe strain, although being an excel-
lent host for selection, is not well-suited for high
yield production of recombinant proteins.
Discussion
TNF-a is a well-suited model to test our system,
because the results from our screening method can
be compared to many existing single amino acid resi-
due substitutions, deletions, and in-frame insertions
in TNF-a, which have previously been investigated
for their effect on folding, structure, and activity.26–
28 TNF-a is a homotrimer, where each monomer
folds into a b-sandwich containing two stacked
b-pleated sheets, each formed by five anti-parallel
b-strands that adopt a classical jelly-roll topology
with loops of variable length protruding out of the
core 29,30 [Fig. (4B)].
Our selection assay identified 14 insertion per-
missive sites in TNF-a. More than half of the inser-
tions were located within the first 26 N-terminal
amino acid residues of TNF-a, which contain b-
strand A. However, most of these sites were located
in the sequence before strand A and in the loop
between strands A and A’ (loop AA’). In the crystal
structure of TNF-a, the first 10 amino acids residues
are disordered, and mutations and deletions in this
region generally do not affect the folding of the pro-
tein.28 In TRAIL, a member of the TNF protein fam-
ily, loop AA’ contains a 15 residue-long extension,
hence permissive insertion sites were to be expected
in loop AA’ of TNF-a. Most of the remaining inser-
tions were found in loops, where structural flexibil-
ity is expected. Interestingly, no insertion was found
in the large flexible loop EF, where we have previ-
ously successfully inserted PADRE by rational
design.26 This may reflect that our library screening
was not exhaustive or that other loops are more per-
missive to insertions than loop EF. Indeed, we have
previously shown that sliding of PADRE by one resi-
due within loop EF can cause misfolding.26
Importantly, one insertion site (variant 11)
would not have been predicted by rational design as
it locates in the buried b-strand F in TNF-a. All
other insertion sites are located near the surface of
the protein [(Figs. 4(B,C)]. This demonstrates the
power of this random genetic screen to uncover
novel permissive insertion sites. We speculate that
the buried PADRE insert integrates as part of the
Figure 2. Growth selection assay on plates to assess the expression of control proteins (A and B) and optimisation of the
glucose concentration in the screening plates (B). (A) The invertase deficient S. pombe strain PY-17 was transformed with an
expression vector containing unfused invertase (cpy-inv), GFP-invertase fusion (cpy-GFP-inv), IL5.14-invertase fusion
(cpy-IL5.14-inv), TNF-a-invertase fusion (cpy-TNF-a-inv), or unfused invertaseQ176R (cpy-invQ176R), an invertase mutant with
reduced activity (unpublished data). The transformants were streaked out on plates containing nonselective (EMM) or
selective (EMM-sucrose) medium. (B) The invertase deficient S. pombe strain PY-17 was transformed with the same
constructs as in (A) and with an expression vector containing invertase with a stop codon inserted between the signal peptide
and the invertase coding region (cpy-stop-inv) or RANKL-invertase fusion (cpy-RANKL-inv). Transformants were directly
plated out onto solid EMM-media containing 2% of glucose (nonselective medium) or 2% of sucrose supplemented with 0,
0.01, 0.02, or 0.03% of glucose (media of different selective pressure). An uneven distribution of colonies at the 0, 0.01, and
0.02% glucose concentrations were observed even though all transformed cells contain plasmids giving a positive phenotype.
This could be due to a higher invertase activity in some colonies because of a higher plasmid copy number in these colonies
resulting to a relatively faster growth rate. These cells then drive the neighbour colonies to grow faster because of cross-
feeding. Alternatively, subtle differences in the environment on the plates, for example, temperatures or moistness result in
the differences in growth rate.
Lyngso/ et al. PROTEIN SCIENCE VOL 19:579—592 585
b-strand causing a lateral displacement of the TNF-
a residues. This extension is then accommodated in
the adjacent EF or FG loop.
The data presented here demonstrate that we
have developed a novel in vivo selection assay for
protein folding, based on genetic complementation of
the selectable growth marker gene invertase in S.
pombe. After testing our assay with six proteins of
known folding competence, we applied it to the
screening of a TNF-a insertion mutant library and
identified 20 unique folding competent TNF-a var-
iants out of the 36,000 transformants screened.
Recombinant expression of five of these TNF-a var-
iants, without the invertase moiety, in two heterol-
ogous cell factories shows that our assay is indeed
predictive of the folding of the target protein during
subsequent recombinant expression in heterologous
production hosts and provides a validation of the
method. Our assay has a number of advantages over
the existing ones. First, as it is a growth-based selec-
tion assay, only transformants expressing a foldable
protein will form colonies. This greatly facilitates
the identification of interesting candidates and the
necessity of replica-plating and top-agar or color
Table I. Subcellular Distribution of Invertase Activity in S. pombe PY-17 Strains Transformed with Control
Proteins Fused to Invertase
Construct Total activity Extracellular activity Activity in culture medium
Cpya <5 <5 <5
Cpy-inv 1287 1261 130
Cpy-TNF-inv 359 337 <5
Cpy-GFP-inv 122 120 <5
Cpy-RANKL-inv 494 485 <5
Cpy-IL5.14-inv 19 16 <5
Cpy-TNF59-inv 50 n.db n.d
Cpy-TNF60-inv <5 n.d n.d
S. pombe cells were grown in EMM-fructose medium ON at 30C. The number of cells in each sample was normalised to
5  106 cells/ml before measuring invertase activity using a quantitative liquid assay16. The invertase assay was performed
on cell cultures (Total activity) as well as on intact cells (Extracellular activity) and culture growth medium, separately. In-
vertase activity is expressed in nanomoles of glucose released per minute per 5  106 cells at 30C. The numbers are aver-
age values from two measurements.
a Cpy, signal peptide of carboxypeptidase Y.
b n.d., not determined.
Figure 3. Expression and sub-cellular localisation of control proteins fused to invertase.(A) Western blot analysis of S. pombe
cell cultures transformed with control proteins GFP, TNF-a, or IL5.14 either without signal peptide or with the signal peptide
of Cpy for extracellular expression (cpy-protein) or with the signal peptide of Cpy and fused to invertase (cpy-protein-inv).
Fifty lg of crude protein extracts from the cell þ cell wall fraction (C þ W) or 10 lL of culture supernatant (S) or 10 lL of 10
 concentrated culture supernatant (10S) were loaded in each lane. (B) Fluorescence microscopy of S. pombe cells
expressing GFP-invertase fusion (cpy-GFP-inv) or TNF-a-invertase fusion (cpy-TNF-a-inv).
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Figure 4. Distribution of insertion sites in the TNF-a structure.(A) Distribution of insertion sites along the TNF-a amino acid
sequence before (upper panel) and after (lower panel) selection. Bars represent insertion sites, and their heights the number
of insertions found at each site. The representation does not discriminate between the different reading frames and
orientations. A two-dimensional representation of TNF-a indicating the positions of b-strands is shown below the diagrams.
Blue rectangles represent b-strands situated in the inner-sheet of the molecule, whereas orange ones represent strands of the
outer-sheet. (B) Graphic 3D representation of insertion points in TNF-a after selection. The TNF-a monomer is displayed as a
solid ribbon with b-strands of the inner- and outer-sheets represented in blue and orange, respectively. The positions of
insertion sites are located C-terminally to the amino acid residues represented in black in the accentuated subunit. For
specific details of the individual insertions see supplementary Figure C. (C) Graphic 3D representation of the TNF-a trimer
from two different perspectives, showing that insertion points are mostly located at the surface of the protein.
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assay16 is reduced or avoided. Second, as it is per-
formed in a eukaryotic host, our system exploits the
elaborate eukaryotic protein quality control, which
could be more stringent than a simple solubility
screen in E. coli. Recently, Boder and coworkers
showed that the protein quality control of a yeast
(Saccharomyces cerevisiae) could not be distin-
guished between folding variants of a highly thermo-
stable nonnatural, de novo-designed protein.31 How-
ever, this seems to highlight a particularity of
proteins of extreme thermostability or of nonnatural
proteins, rather than a general limitation of the eu-
karyotic protein quality control.
Our assay is simple, fast, has a low frequency of
false positives, and is well-suited for high-through-
put screening of large protein libraries. The uncov-
ered foldable sequences can then be expressed in a
suitable expression host for example, insect cells as
demonstrated here. Our approach is versatile, as no
structural or functional information on the target
protein is required apart from its sequence and
many modifications including point mutations, inser-
tions, or deletions may be analyzed, making our
approach universal. In conclusion, the assay pre-
sented here is a true folding assay combining the
simplicity of the E. coli on-plates systems with the
advantages and versatility of a eukaryotic system.
Materials and Methods
All standard cloning procedures were carried out
according to Sambrook and Russell (2001).32 Restric-
tion enzymes and T4 ligase were purchased from
New England Biolab and primers from DNA technol-
ogy. PCR reactions were performed using Expand
PCR system (Roche) according to the manufacturer’s
instructions. The prepared plasmids were trans-
formed into E. coli ElectroMAXTM DH10BTM
Table II. Distribution of Epitope Insertion Sites and Orientation
Insert seq.
frequency
prior
selection
RF of insertion point (33%)
Resulting insert
DNA seq. (16%)
Resulting amino
acid insert seq.
Translated
seq prior
selection (25%)
pUC19
library S. pombe library Total
A
RF1-d (PADRE) 6 (33%) 10 (38%) 16 (36%) 6 (13%) AAAKFVAAWTLKAAA 6 (22%)
RF1-r 10 (22%) AAALRVQAATNLAAA 10 (37%)
RF2-d 5 (28%) 8 (31%) 13 (30%) 4 (9%) RPLSSLQLGPLRRPQ 4 (14%)
RF2-r 9 (20%) LRPP*GSKLQRT*RP –
RF3-d 7 (38%) 8 (31%) 15 (34%) 8 (20%) CGR*VRCSLDP*GGR –
RF3-r 7 (16%) CGRLKGPSCNELSGRT 7 (25%)
Total 18 26 44 44 27
Insert seq.
frequency
after selection
RF of insertion point
Resulting insert
DNA seq. (25%)
Resulting amino acid
insert seq.
Translated
seq after
screen (25%)
S. pombe
library
Expected ratio
if no bias
B
RF1-d (PADRE) 13 (60%) 50% 6 (27%) AAAKFVAAWTLKAAA 6 (27%)
RF1-r 7 (32%) AAALRVQAATNLAAA 7 (33%)
RF2-d 3 (13%) 25% 3 (13%) RPLSSLQLGPLRRPQ 3 (13%)
RF2-r 0 LRPP*GSKLQRT*RP –
RF3-d 6 (27%) 25% 0 CGR*VRCSLDP*GGR –
RF3-r 6 (27%) CGRLKGPSCNELSGRT 6 (27%)
Total 22 22 22
The insert can be found in three reading frames (RF1, RF2, RF3) and in two orientations (d: direct or r: reverse) translat-
ing into 6 different insert sequences, two of which contain stop codons (See supporting data C). Frequency of each possible
insert sequence in TNF-a in 44 clones picked randomly in the library for sequence analysis before selection (Panel A) and
in 22 clones isolated from the library after selection (Panel B).
Table III. Number of Colonies Obtained After Each Screening Step Using Three Different Selection Pressures
Glucose concentration 0.01% 0.02% 0.03% Total
Number of screened colonies 12,000 12,000 12,000 36,000
Positive colonies before restreak 18 7 1,068 (11) 36 (0.1%)
Positive colonies after restreak 12 5 9 26 (0.07%)
Colonies obtained on 0.03% glucose medium were subjected to an additional round of selection on sucrose medium; the
resulting number of colonies is given in parenthesis.
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(Invitrogen) by electroporation using a Gene Pulser
II (Bio-Rad) and grown in liquid or agar solid LB-
media (Invitrogen) containing 50 lg/mL carbencillin
(Sigma). All plasmids are sequenced in a region cov-
ering modifications to check the fidelity of the con-
structs, using the BigDye kit (Applied Biosystem) on
an ABI PRISM 310 Sequence analyzer (Applied
Biosystem).
Construction of the S. pombe invertase
knock-out strain
The S. pombe invertase knockout strain PY-17
(mat1-P Dmat2,3::LEU2 leu1 Dinv1::ura4þ) was
generated from Eg660 obtained from O. Nielsen
(University of Copenhagen). The inv1 locus was dis-
rupted in the Eg660 wild type S. pombe strain
(kindly provided by O. Nielsen, University of Copen-
hagen) by replacing the complete open reading
frame of inv1 with the S. pombe ura4 gene to pro-
duce the strain, mat1-P Dmat2,3::LEU2 leu1 Dinv1
(PY-17). Approximately, 1000 bp of sequences
upstream of the initiating ATG of inv1 was amplified
by PCR using S. pombe genomic DNA as template
and the following oligonucleotides: 50-ATCTAGACA
AAATACATCTTATGTATTGAACATTAGAAG-30 and
50-AGAATTCGCAAATGCCACTAGCTAAAATATATT
TC-30. Around 1000 bp of sequences located down-
stream of the inv1 stop codon was amplified by PCR
using S. pombe genomic DNA as template and the
following oligonucleotides: 50-AATCGATGCCATTAA
AGACTATCTGGAATTGC-30 and 50-AGGTACCTTGC
AAACAATACA TATTTGTGG-30. The two PCR prod-
ucts were linked to the S. pombe ura4 gene through
EcoRI and ClaI sites and the chimeric molecule was
inserted into pBluescriptIISK() using KpnI and
XbaI sites. A linearized DNA fragment carrying the
disrupted inv1 gene was used to transform a wild-
type haploid strain. To confirm the disruption of the
inv1 gene, uraþ transformants were analyzed by
PCR to verify correct integration of construct.
Construction of the screening vector
A 1680 bp fragment encoding amino acids 23–581 of
inv1 was amplified by PCR using S. pombe genomic
DNA as template and the following oligonucleotides:
50-ACCATGGCTCCCCGTCA CTTATATGTAA-30 and
50-AGCGGCCGCTTAGCAATTCCAGA TAGTCTTTA
ATG-30. The resulting PCR product was digested
with Nco1 and Not1 and inserted into Nco1/Not1 re-
stricted pCpy-GFP3, thereby fusing the inv1 gene
with the Cpy secretion signal sequence (pNMT-Cpy-
inv1). Next, the screening vector (pCpy-inv1-lib) was
generated for in-frame insertion of protein encoding
libraries between the Cpy signal peptide and the
inv1 gene. First, the Sac1 site found the down-
stream of the nmt terminator in the pNMT-Cpy-inv1
vector was destroyed by Sac1 restriction followed by
end-filling with T4 DNA polymerase and religation.
Second, a stop codon and a Sac1 site were inserted
immediately after the Nco1 site located in the fusion
point of the Cpy signal sequence and inv1 gene as
described in the following. The 50 of the inv1 gene
was amplified by PCR using the oligonucleotides:
50-TATCCATGGCATGAGCTCCCCGTCACTTATATG
TAAAACG-30 and 50-CAGTGGTATACGCAATAGC
CTG-30. The PCR product was restricted with NcoI
and BspEI and ligated into Nco1/BspEI digested
pNMT-Cpy-inv1, creating the final screening vector.
For cloning of the library into the expression cas-
sette the recognition sequences for the restriction
enzymes Nco1 and Sac1 are situated between Cpy
and invertase. In between these restriction sites a
stop codon is placed in-frame of the invertase gene
to prevent background from uncut or religated plas-
mids in the screen. The library of variants was
cloned from the pUC19-based library plasmid by
excising the sequences by Nco1 and Sac1 restriction
and ligating into Nco1/Sac1 digested screening
plasmid.
Construction of TNF-a variant library
For insertion mutagenesis, the MuA transposon kit
from Finnzymes was used according to the
Figure 5. Recombinant expression of TNF-a vaccine
candidates in S. pombe, E. coli, and Drosophila S2 cells.
Wild-type TNF-a, clones 4, 7, 12, 18, 25, and the negative
control clones 59 and 60 were expressed without the
invertase moiety in S. pombe, E. coli, and Drosophila cells.
(A) The protein concentrations of the various TNF-a species
were determined using a quantitative sandwich ELISA
specific for TNF-a. ELISA was performed on culture
supernatants (S. pombe and Drosophila cells) or on cell-
free protein extracts (E. coli) and plotted as a logarithmic
histogram. (B) Western blot analysis of culture supernatants
from 4-day old Drosophila S2 cell cultures. 25 lL samples
were loaded in each lane. The name of each variant is
indicated above the individual lanes. 50 (first lane from left)
and 100 ng (second lane from left) of pure wild-type TNF-a
protein were loaded as controls.
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manufacturer’s directions. The template DNA was
made by PCR amplification of a human wt-TNF-a
synthetic gene made by GeneArt GMBH, using the
primers 50-GCACCATA TGCCATGGTGCGCT-
CAAGCTCGCGCACGCCGA-30 and 50-TTACGC-
CAAGCTTGAGCTCCCAATGCGAT AATGCCGAAG-
TAGACC-30. Fragments were ligated into Nde1 and
Hind III -digested pUC19 plasmid (Invitrogen).
The TNF-a coding expression cassette contain-
ing transposon inserts was removed from the vector
using Nde1/Sac1 double digestion and reintroduced
into a fresh pUC19 plasmid to remove plasmid con-
taining transposon insertions outside of TNF-a. The
transposon was then removed by the restriction
enzyme Not1 followed by de-phosphorylation, and
interchanged with insert fragment encoding PADRE
flanked by Not1 restriction sites. For details see
Figure 1(A) and Supporting Information Figure (B).
As the insert integrates in all the three reading
frames and in both orientations, it results in six dif-
ferent insert sequences. One of these insertions
equals the epitope, three others result in different
ORF peptides, and two introduce a stop codon in the
TNF-a cDNA sequence. Hence, the library comprises
cDNA species encoding TNF-a variants with inserts
of four different amino acid sequences and nonpro-
ductive species (variants with stop codons).
To make the PADRE insert the two primers 50-GC
GGCCGCTAAGTTCGTTGCAGCTTGGACCCTTAAGG
CGG-30 and 50-CCGCCTTAAGGGTCCAAGCTGCAAC
GAACTTAGCGGCCGC-30 were annealed and cloned
into Not1-digested pVAX vector (Invitrogen). The Not1
restriction site adds two additional alanines to the
insert sequence. This plasmid was amplified in E. coli
and the PADRE insert was recovered by Not1
digestion.
Immunocytochemistry
About 2  106 cells were labeled with antibodies as
described elsewhere.33 For labeling of TNF-a, mono-
clonal antibody Hyb 256-01 was used (1 lg in
100 lL of 50 mM Tris-Cl, 150 mM NaCl, 0.1% BSA,
pH 8.0), followed by incubation with rabbit anti-
mouse Alexa 488 (Molecular Probes, 1 lg in 100 lL
of same buffer as above). The microscopic analysis
was performed using an Axioplan 2 (Carl Zeiss)
microscope equipped with a MicroMax (Roper Scien-
tific) cooled CCD camera and MetaMorph software
(Universal Imaging).
S. pombe screening
S. pombe transformations were performed using a
PEG/lithium acetate procedure.14 Transformants
were washed twice in media without glucose before
plating. S. pombe cells were grown at 30C. EMM-
media with the different carbon sources were pre-
pared as described elsewhere.15 Selection media
were always freshly made with filter-sterilized ultra
pure sucrose (Invitrogen, Cat. #15503-022). The
number of transformants was estimated to be
 4,000 on each 10 cm dish based on the number of
colonies appearing on the nonselective 2% glucose
media.
S. pombe plasmid rescue, colony PCR,
and invertase assay
A single colony was inoculated in 5 mL EMM-su-
crose media and grown at 30C until cell density
had reached 1  107 cells/mL. For invertase assay,
cells were diluted exactly 5  106 cells/mL, and then
the assay was preformed as described elsewhere.16
For colony PCR cells from 1 mL culture were mixed
with 500 lL extraction buffer and 250 lL glass
beads. Cell disruption was then performed mechani-
cally by Fastprep for 15 s. After 1 min centrifugation
at 13,000 rpm, 1 lL supernatant was used for a
PCR with the primers 50-CGTTTTACATATAAGTG
ACGGGGAGCTCAGAGGG-C30 and 50-0CCGGGTCAT
CATTACTATTACTAACGAGCT-30. For plasmid res-
cue cells were harvested and washed once in 5 mL
milliQ H2O. 500 lL extraction buffer (100 mM Tris
pH 7.6, 10 mM EDTA, 1% SDS, 0.2M NaCl) and
glass beads until 2 mm below the liquid surface
were added. Plasmids were extracted using phenol/
chloroform extraction. Briefly, after addition of
500 lL phenol/ chloroform/isoamylalcohol (25:24:1),
cells were mechanically disrupted for 15 s in Fast-
prep. The phenol phase was removed after 5 min
centrifugation at 20,000 rpm. A second phenol
extraction was performed and the DNA extracted by
EtOH precipitation. The plasmid preparation was
transformed into DH10B (Invitrogen) and plasmids
were sequenced.
Recombinant expression of TNF-a variants
in S. pombe
The expression cassettes of the TNF-a variants were
amplified by PCR using the primers 50-CG TTTTA-
CATATAAGTGACGGGGAGCTCAGAGGGC-30 and
50-CCGGGTCATCATTACTATTACTAACGAG CT-30
and cut with the restriction enzymes Nco1 and Hin-
dIII and cloned into the screening vector also line-
arised with Nco1 and HindIII, hereby removing the
invertase moiety. The plasmid was transformed into
PY-17. A single S. pombe colony was grown ON in a
3 mL preculture EMM-glucose medium containing
2% broad bean peptone and 15 lM thiamine to sup-
press the promoter. The ON cultures were used to
inoculate fresh expression medium at OD600 ¼ 0.2.
The expression medium was 10 mL EMM-glucose
medium containing 5% broad bean peptone (Fluka)
and CS-LEU amino acid supplement (Q-BIO gene),
but no thiamine. Culture supernatants were har-
vested by centrifugation after 30 h of growth.
Growth media were used for protein quantification
and expression level was normalised relative to the
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OD600 value of the single cultures at the time of
harvest.
Recombinant expression of TNF-a variants
in E. coli
The expression cassettes of the TNF-a variants were
amplified by PCR using 50-CGTTTTACATATAAGTG
ACGGGGAGCTCAGAGGGC-30 and 50-CCGGGTCAT
CATTACTATTACTAACGAGCT-30 and cloned into
the pET28b vector by standard techniques using the
restriction enzymes Nco1 and HindIII. E. coli Bl21-
star, containing the various expression constructs,
were grown to mid-log phase (OD600 ¼ 0.4) in 50 mL
LB media with 60 ug/mL kanamycin (Sigma). Then
the expression was induced with addition of 0.7 mM
IPTG (Boehringer Mannheim) and cells were further
cultivated for 5 h. 1 mL of cells was harvested, pel-
leted, and resuspended in 1 mL of sonication buffer
[20 mM Bis-Tris pH 6.0,40 mM NaCl, 10 mM EDTA,
containing CompleteTM protease inhibitor (Roche)].
Cells were sonicated on ice 4 times for 15 s, with
20 s pauses, and centrifuged at 20,000 rpm at 4C
for 20 minutes. Cell-lysis supernatants were used
for protein quantification.
Recombinant expression of TNF-a variants
in Drosophila S2 cells
The TNF-a and variants cDNA were amplified from
the screening vector by the primers 50-TCAGCTGAA
TTCCCGATCTCAATATGAAGTTATGCATATTACTG
GCCGTCGTGGCCTTTGTTGGCCTCTCTGGGATGG
TCAGATCATCTTCTCGAACCCCG-30 and 50-CGGT
CTAGAGGATCCATCACTATTAGAGGGCAATGATCC
CAAAGTAGACCTGCCC-30. The 50 includes the sig-
nal sequence of Bip, for directing the protein
through the secretory pathway. The fragment was
then introduced into p2Zop2F vector linearised with
the restriction enzymes HindIII and BamHI.
Drosophila S2 cells (ATCC CRL-1963) were used as
expression host and plasmid transfection was done
using the Saint-18 transfection reagent (Cytotech)
according to the manufacturer’s instructions. Cells
were grown in 4 mL Excell-420 media (JRH Bio-
sciences) with 10% FBS in 25 cm2 T-flasks at 37C
for 4 days.
Quantification of TNF-a variants using ELISA
The assay was performed as described previously,26
with the following modifications. Maxisorp micro-
titer plates were coated with 100 lL of antimouse
antibody (Dako Z0109), diluted 1:1000 in carbonate
0.1M, and pH 9.0. After blocking (1% BSA in PBS,
pH 7.2) 100 lL of MAB210 (R&D Biosystems)
diluted to 0.5 lg/mL in ELISA buffer (1% BSA,
0.05% Tween 20 in, PBS, pH 7.2) was transferred to
the plates.
Western blots
Following electrophoresis on NuPAGE 4–12% SDS
gels (Invitrogen), protein samples were transferred
onto nitrocellulose membranes by semidry blotting.
For immunoreaction incubation with rabbit TNF-a
antiserum (1 h; dilution 1:10,000) or rabbit IL-5
antiserum or rabbit GFP antiserum (Abcam 6556)
and with horse radish peroxidase-conjugated second-
ary antibody (Dako P448) was carried out in Tris 50
mM, NaCl 150 mM, EDTA 5 mM, Igepal 0.1%, and
gelatin 0.5%. Antibodies were diluted 1:10,000 and
incubations were performed at room temperature for
1 h. Detection was with ECLTM reagents (GE
Healthcare).
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